share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer BOURLA ALBERT

Pfizer | 4: Statement of changes in beneficial ownership of securities

輝瑞 | 4：持股變動聲明
SEC announcement ·  04/12 02:55
牛牛AI助理已提取核心訊息
Pfizer Inc. (PFE) Chairman & CEO Albert Bourla executed a transaction of non-derivative securities on April 10, 2024. The specific details of the transaction, including the number of shares, transaction price, and total value, were not disclosed in the announcement. Bourla's relationship with the company as Chairman & CEO places him in a position of significant influence, and such transactions are closely watched by investors for indications of executive confidence in the company's performance and outlook.
Pfizer Inc. (PFE) Chairman & CEO Albert Bourla executed a transaction of non-derivative securities on April 10, 2024. The specific details of the transaction, including the number of shares, transaction price, and total value, were not disclosed in the announcement. Bourla's relationship with the company as Chairman & CEO places him in a position of significant influence, and such transactions are closely watched by investors for indications of executive confidence in the company's performance and outlook.
輝瑞公司（PFE）董事長兼首席執行官阿爾伯特·布爾拉於2024年4月10日執行了一筆非衍生證券交易。公告中未披露該交易的具體細節，包括股票數量、交易價格和總價值。Bourla作爲董事長兼首席執行官與公司的關係使他處於重要的影響力，此類交易受到投資者的密切關注，以尋找高管對公司業績和前景充滿信心的跡象。
輝瑞公司（PFE）董事長兼首席執行官阿爾伯特·布爾拉於2024年4月10日執行了一筆非衍生證券交易。公告中未披露該交易的具體細節，包括股票數量、交易價格和總價值。Bourla作爲董事長兼首席執行官與公司的關係使他處於重要的影響力，此類交易受到投資者的密切關注，以尋找高管對公司業績和前景充滿信心的跡象。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。